Drug Shortage Report for OCTREOTIDE ACETATE OMEGA

Last updated on 2026-02-23

Report ID 277213
Drug Identification Number 02248641
Brand name OCTREOTIDE ACETATE OMEGA
Common or Proper name OCTREOTIDE ACETATE INJECTION
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) OCTREOTIDE
Strength(s) 500MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 5 x 1mL vial / fiole
ATC code H01CB
ATC description HYPOTHALAMIC HORMONES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2026-02-03
Estimated end date 2026-03-02
Actual end date 2026-02-18
Shortage status Resolved
Updated date 2026-02-23
Company comments Product available at CPDN and McKesson
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2026-02-23 French Compare
v5 2026-02-23 English Compare
v4 2026-02-18 French Compare
v3 2026-02-18 English Compare
v2 2026-02-03 French Compare
v1 2026-02-03 English Compare

Showing 1 to 6 of 6